Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants — Stella

Home/Malaria, Falciparum/A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

View on ClinicalTrials.gov

Recruiting

Back to Malaria, Falciparum trials

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United Kingdom

GSK Investigational Site, Cambridge

Key details

Phase

Early testing

Sponsor

GlaxoSmithKline

Enrollment target

~156 participants

Started

December 2023

Primary completion

August 2026

Age range

18 Years – 60 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.